Just a few years after mRNA vaccines proved their effectiveness against COVID-19, scientists are now looking at how they can be used to treat other serious diseases — including lung cancer. Researchers are beginning clinical trials using the technology to create a vaccine to treat non-small-cell lung cancer (NSCLC), the most common form of the disease.
Health
Scientists launch 1st lung cancer vaccine clinical trials using COVID-19 mRNA technology
More Videos
-
Doctors concerned about vaccine rates across Canada
-
AI model developed at Toronto hospital helps doctors triage brain surgery
-
Ants could help find new antibiotics, scientists say
-
McGill’s LGBTQ2+ mental health clinic marks 25th anniversary
-
What Canadians need to know about the Bird Flu crisis
-
Health Matters: Nestle launches protein shots in U.S.
You are viewing an Accelerated Mobile Webpage.
View Original Article